Board Meetings for ZYDUSLIFE

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
ZYDUSLIFEZydus Lifesciences Limited13 Nov 2019Financial ResultsTo consider and approve the financial results for the period ended September 30, 2019
ZYDUSLIFEZydus Lifesciences Limited09 Aug 2019Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2019
ZYDUSLIFEZydus Lifesciences Limited29 May 2019Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2019 and dividend
ZYDUSLIFEZydus Lifesciences Limited07 Feb 2019Financial ResultsTo consider and approve the financial results for the period ended December 31, 2018
ZYDUSLIFEZydus Lifesciences Limited03 Nov 2018Financial Results/Other business mattersTo consider apart from other agenda items to approve the unaudited financial results for the quarter / half year ended on September 30, 2018.
ZYDUSLIFEZydus Lifesciences Limited03 Nov 2018Financial ResultsTo consider and approve the financial results for the period ended September 30, 2018
ZYDUSLIFEZydus Lifesciences Limited13 Aug 2018Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2018
ZYDUSLIFEZydus Lifesciences Limited25 May 2018Fund RaisingFurther to our earlier intimation dated May 4, 2018 regarding board meeting, the Board of Directors [the Board] shall also consider the following proposals:(i) to raise funds by issue of Equity Shares / convertible Bonds / Debentures through Qualified Institutional Placement [QIP] / GDR / ADR, subject to approval of the shareholders,(ii) to issue Secured / Unsecured Redeemable Non-Convertible Debentures / Foreign Currency Bonds on Private Placement Basis, subject to approval of the shareholders and(iii) to issue Foreign Currency Bond / Foreign Currency Convertible Bonds subject to the approval of the shareholders.
ZYDUSLIFEZydus Lifesciences Limited25 May 2018Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2018 and dividend
ZYDUSLIFEZydus Lifesciences Limited08 Feb 2018Results/OthersTo consider apart from other agenda items to approve the unaudited financial results for the quarter / nine months ended on December 31, 2017.
ZYDUSLIFEZydus Lifesciences Limited14 Nov 2017ResultsTo consider apart from other agenda items to approve the unaudited financial results for the quarter / half year ended on September 30, 2017.
ZYDUSLIFEZydus Lifesciences Limited11 Aug 2017Resultsto consider, inter alia, approve the unaudited financial results for the quarter ended on June 30, 2017.
ZYDUSLIFEZydus Lifesciences Limited26 Jun 2017Raising of FundsTo consider the following proposals: (i) to raise funds by issue of Equity Shares / convertible Bonds / Debentures through Qualified Institutional Placement [QIP] / GDR / ADR, subject to approval of the shareholders, (ii) to issue Secured / Unsecured Redeemable Non-Convertible Debentures / Foreign Currency Bonds on Private Placement Basis, subject to approval of the shareholders and (iii) to issue Foreign Currency Bond / Foreign Currency Convertible Bonds subject to the approval of the shareholders.
ZYDUSLIFEZydus Lifesciences Limited27 May 2017ResultsTo consider, inter alia, to approve the Audited Financial Results for the year ended on March 31, 2017.
ZYDUSLIFEZydus Lifesciences Limited07 Mar 2017Dividendto consider, the proposal of declaration of Interim Dividend, if any, for the financial year 2016- 2017.
Showing page 4 of 8 (118 total items)